Remove 2023 Remove Diagnose Remove Healthcare Professional Remove IT
article thumbnail

Should you have a coach? Greg Pawlson, Beth Griffiths, & Vicky Tang

GeriPal

Hot off the presses RCT in JAMA October 2023: Study that looks at 1000 female resident physicians at 26 sites that showed that coaching improved each outcome assessed (burnout, moral injury, imposter syndrome, self-compassion, and flourishing). [link] 2. Summary Transcript Summary Coaching is in. We address: What is coaching? AlexSmithMD 1.

article thumbnail

Leveraging U=U Interventions for Black Women With HIV

Physician's Weekly

The systematic review of peer-reviewed intervention was published from 2018 to 2023. This message should be incorporated into counseling during routine clinic visits, especially for people recently diagnosed with HIV. Of the 669 participants, the mean age from studies was 45.4 PW: Why was it important to do this study?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is Hospice Losing Its Way: A Podcast with Ira Byock and Joseph Shega

GeriPal

JAMA IM 2023 A shout-out to my NPR episode on 1A titled the “State of Hospice Care” DISCLAIMER While we filmed in Montreal during the Annual Assembly, all opinions expressed in this podcast are independent of AAHPM and HPNA, or the Annual Assembly. JAMA IM 2021 Hospice Acquisitions by Profit-Driven Private Equity Firms. JAMA Health Forum.

IT 113
article thumbnail

When to Go to Urgent Care for a Sore Throat: How Can Urgent Care Help?

Doctor On Demand

Urgent care clinics provide quick diagnoses and treatments, including antibiotics if needed. In fact, most sore throat symptoms resolve in three days for 60-70% of patients, according to March 2025 UpToDate, an evidence-based clinical decision support system used by healthcare professionals.

ER 52
article thumbnail

Amyloid Antibodies and the Role of the Geriatrician: Nate Chin, Sharon Brangman, and Jason Karlawish

GeriPal

The outlook on amyloid antibodies are looking brighter though in 2023. Summary Transcript Summary It’s been over two years since one of the worst product launches of all time – Aduhelm (aducanumab). This led the FDA to give full approval for lecanemab, which will likely be followed by full approval of donanemab sometime this year.

article thumbnail

What can we learn from simulations? Amber Barnato

GeriPal

And so I think that’s why it has its moment now even in 2023. We’re going to define what that is and how it applies to the work that we do. But before we go into that, Amber, I think you got a song request for Alex. Amber: I do. You know what? So I just can’t keep going. Alex: That’s great. I love this song.

article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

Summary Transcript Summary We’ve talked a lot about comprehensive dementia care on the GeriPal podcast but while the evidence is clear that these programs work, the uptake has been limited largely because there hasn’t been a strong financial case for it. It requires a fight. It’s been going on for many decades now. Malaz: I love it.